Exclusive

Publication

Byline

Location

Clinical Trial: Clinical Assessment of Nutritional Therapy Awareness, Practice, and Collaboration for Liver Cirrhosis: An Internet Survey (Japan)

Tokyo, April 28 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061366) titled 'Clinical Assessment of Nutritional Therapy Awareness, Practice, and Collab... Read More


Clinical Trial: Evaluation of the Effect of Oxygen Inhalation on Learning Efficiency (Japan)

Tokyo, April 29 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061406) titled 'Evaluation of the Effect of Oxygen Inhalation on Learning Efficiency' on A... Read More


Clinical Trial: Evaluation of the Utility of a Novel Nucleosome Biomarker Associated with Neutrophil Extracellular Traps (Japan)

Tokyo, April 29 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061401) titled 'Evaluation of the Utility of a Novel Nucleosome Biomarker Associated with ... Read More


Clinical Trial: Association Between Glycemic Measures and Periodontal Parameters in Patients with Periodontal Disease Attending Dental Clinics: Detection of Impaired Glucose Tolerance Using Blood Glucose and HbA1c (Japan)

Tokyo, April 29 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061400) titled 'Association Between Glycemic Measures and Periodontal Parameters in Patien... Read More


Clinical Trial: A Retrospective Study of the Effects of Pemafibrate in Patients with Dyslipidemia Complicated by Metabolic Dysfunction-Associated Steatotic Liver Disease (Japan)

Tokyo, April 29 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061398) titled 'A Retrospective Study of the Effects of Pemafibrate in Patients with Dysli... Read More


Singapore Clinical Trial: A Global Multicenter, Open Label, Randomized Phase 3 Registrational Study of Olverembatinib Combined with Chemotherapy Versus Investigator’s Choice of TKI Combined with Chemotherapy in Patients with Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph+ ALL)

Singapore, April 27 -- The Health Sciences Authority received information related to the study titled 'A Global Multicenter, Open Label, Randomized Phase 3 Registrational Study of Olverembatinib Combi... Read More


Singapore Clinical Trial: 'Establishing the role of mitomycin C and systemic non-steroidal anti-inflammatory drugs in the post-operative survival of glaucoma drainage devices'

Singapore, April 27 -- The Health Sciences Authority received information related to the study titled ''Establishing the role of mitomycin C and systemic non-steroidal anti-inflammatory drugs in the p... Read More


Singapore Clinical Trial: IZABRIGHT-Lung01: A Randomized, Open-label, Phase 2/3 Study of Izalontamab Brengitecan (BMS-986507) versus Platinum-based Chemotherapy in Patients with EGFR-mutated Non-small Cell Lung Cancer and Disease Progression on EGFR Tyrosine Kinase Inhibitor Therapy.

Singapore, April 27 -- The Health Sciences Authority received information related to the study titled 'IZABRIGHT-Lung01: A Randomized, Open-label, Phase 2/3 Study of Izalontamab Brengitecan (BMS-98650... Read More


Singapore Clinical Trial: ROSETTA CRC-203: A Blinded, Randomized Phase 2/3 Study of Pumitamig in Combination with Chemotherapy Versus Bevacizumab in Combination with Chemotherapy in Participants with Previously Untreated, Unresectable, or Metastatic Colorectal Cancer

Singapore, April 27 -- The Health Sciences Authority received information related to the study titled 'ROSETTA CRC-203: A Blinded, Randomized Phase 2/3 Study of Pumitamig in Combination with Chemother... Read More


Singapore Clinical Trial: A Phase 3, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Safety and Efficacy of L606 (Treprostinil Liposome Inhalation Suspension) in Participants with Pulmonary Hypertension Associated with Interstitial Lung Disease (WHO Group 3)

Singapore, April 27 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Safe... Read More